• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

截至2015年爱尔兰前列腺癌死亡率预测。

Prostate cancer mortality predictions for Ireland up to 2015.

作者信息

O'Lorcain Piaras, Comber Harry

机构信息

National Cancer Registry, Elm Court, Cork, Ireland.

出版信息

Eur J Cancer Prev. 2007 Aug;16(4):328-33. doi: 10.1097/01.cej.0000236248.63489.4c.

DOI:10.1097/01.cej.0000236248.63489.4c
PMID:17554205
Abstract

The objective of this analysis was to predict average world age-standardized mortality rates per person-years (100,000 person-years) and numbers of prostate cancer deaths in Ireland for the years 2005, 2010 and 2015. Poisson linear and log-linear regression models of Irish prostate cancer mortality data for the years 1950-2002 were used to predict trends for the whole population, for men aged 0-64 and 50-74 years. The prostate cancer world age-standardized mortality rate in 2015 is predicted to remain unchanged from the average recorded in 1998-2002, while, because of population growth, the number of deaths is predicted to increase. In persons under 65 years of age, the world age-standardized mortality rate is expected to increase, but the number of deaths in this age group is expected to nearly double between 2002 and 2015. Similarly, the world age-standardized mortality rate for men aged 50-74 years is predicted to rise with the number of deaths in this age group expected to increase sharply. The historical evidence predicts a small increase of age-adjusted prostate cancer mortality rates in Ireland and only in the age groups of 0-64 and 50-74 years in the next 10 years, along with a continuing marked increase in number of deaths due to demographic change.

摘要

本分析的目的是预测2005年、2010年和2015年爱尔兰人均年(每10万人年)的世界年龄标准化死亡率以及前列腺癌死亡人数。利用1950 - 2002年爱尔兰前列腺癌死亡率数据的泊松线性和对数线性回归模型,预测了全体人口、0 - 64岁男性以及50 - 74岁男性的趋势。预计2015年前列腺癌的世界年龄标准化死亡率将保持在1998 - 2002年记录的平均水平不变,而由于人口增长,预计死亡人数将会增加。在65岁以下人群中,预计世界年龄标准化死亡率将会上升,不过该年龄组的死亡人数预计在2002年至2015年间将几乎翻倍。同样,预计50 - 74岁男性的世界年龄标准化死亡率将会上升,该年龄组的死亡人数预计将大幅增加。历史证据预测,未来10年爱尔兰年龄调整后的前列腺癌死亡率将略有上升,且仅在0 - 64岁和50 - 74岁年龄组出现上升,同时由于人口结构变化,死亡人数将持续显著增加。

相似文献

1
Prostate cancer mortality predictions for Ireland up to 2015.截至2015年爱尔兰前列腺癌死亡率预测。
Eur J Cancer Prev. 2007 Aug;16(4):328-33. doi: 10.1097/01.cej.0000236248.63489.4c.
2
Mortality predictions for colon and anorectal cancer for Ireland, 2003-17.2003 - 2017年爱尔兰结肠癌和肛管癌的死亡率预测
Colorectal Dis. 2006 Jun;8(5):393-401. doi: 10.1111/j.1463-1318.2006.00951.x.
3
Modelling predictions of cancer deaths in Northern Ireland.北爱尔兰癌症死亡人数的建模预测。
Ulster Med J. 2006 May;75(2):120-5.
4
Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.在年龄范围广泛的队列中,按随访时间划分的平均年龄和平均预期死亡率的变化情况。
J Insur Med. 2006;38(3):181-91.
5
Lung cancer mortality predictions for Ireland 2001-2015 and current trends in North Western Europe.2001 - 2015年爱尔兰肺癌死亡率预测及西北欧当前趋势
Lung Cancer. 2004 Nov;46(2):157-63. doi: 10.1016/j.lungcan.2004.04.035.
6
Cumulative cancer mortality risk and potential years of life lost to 64 years of age in Ireland, 1953-2002.1953 - 2002年爱尔兰64岁之前的累积癌症死亡风险及潜在寿命损失年数。
Eur J Cancer Prev. 2007 Jun;16(3):167-77. doi: 10.1097/01.cej.0000228408.68353.ba.
7
Cellular telephone use and time trends in brain tumour mortality in Switzerland from 1969 to 2002.1969年至2002年瑞士手机使用情况及脑肿瘤死亡率的时间趋势
Eur J Cancer Prev. 2007 Feb;16(1):77-82. doi: 10.1097/01.cej.0000203618.61936.cd.
8
Trends in pediatric and adult bicycling deaths before and after passage of a bicycle helmet law.自行车头盔法通过前后儿童和成人自行车死亡趋势。
Pediatrics. 2008 Sep;122(3):605-10. doi: 10.1542/peds.2007-1776.
9
High prostate cancer mortality in Norway evaluated by automated classification of medical entities.通过医学实体自动分类评估挪威前列腺癌的高死亡率。
Eur J Cancer Prev. 2008 Aug;17(4):331-5. doi: 10.1097/CEJ.0b013e3282f5220d.
10
[Incidence and mortality of prostate cancer in France: trends between 1978 and 2000].[法国前列腺癌的发病率和死亡率:1978年至2000年的趋势]
Prog Urol. 2003 Dec;13(6):1334-9.

引用本文的文献

1
Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.生成去势抵抗性前列腺癌相关成本和利用率方面的挑战。
J Mark Access Health Policy. 2014 Jul 4;2. doi: 10.3402/jmahp.v2.24072. eCollection 2014.
2
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes.在前列腺肿瘤中强制表达LIGHT可克服调节性T细胞介导的免疫抑制,并通过募集效应T淋巴细胞与前列腺肿瘤治疗性疫苗协同作用。
Prostate. 2015 Feb 15;75(3):280-91. doi: 10.1002/pros.22914. Epub 2014 Nov 14.
3
Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.
爱尔兰根治性前列腺切除术病理结局的新型预测工具:研发与验证。
Ir J Med Sci. 2010 Jun;179(2):187-95. doi: 10.1007/s11845-009-0393-6. Epub 2009 Jul 14.